Log In
Print
BCIQ
Print
Print this Print this
 

Bioabsorbable Cardiac Matrix (BCM) device (BL-1040, IK-5001)

  Manage Alerts
Collapse Summary General Information
Company BioLineRx Ltd.
DescriptionBiodegradable injectable liquid polymer designed to support damaged heart tissues following a myocardial infarction (MI)
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentPivotal
Standard IndicationMyocardial infarction (MI)
Indication DetailsPrevent deterioration of the myocardium following myocardial infarction (MI); Prevent ventricular remodeling and congestive heart failure (CHF) following acute myocardial infarction
Regulatory Designation
Partner Bellerophon Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$282.5M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today